| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5877983 | Journal of Pain and Symptom Management | 2015 | 12 Pages |
Abstract
In this population, there was no difference between analgesic response or adverse reactions to oral morphine and oxycodone when used as a first- or second-line opioid. These data provide evidence to support opioid switching to improve outcomes.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Julia FRCP, MD, Ruth MRCP, PhD, Joanne MRCP, PhD, Sophy MRCP, PhD, Hiroe MD, PhD, Alison RGN, Christina BSc, Michael FRCS, Athol FRCP, MD, John FRCA, Ken FRCP (Hons), PhD, Joy FRCP, PhD,